Sinergium Biotech

Sinergium Biotech is an active Argentine biopharmaceutical company specializing in the research, development, production, and commercialization of vaccines and complex biopharmaceutical products. It operates a state-of-the-art GMP-certified facility in Buenos Aires Province. The company has established major strategic partnerships with global pharmaceutical leaders such as Novartis/Seqirus (influenza vaccine), Pfizer (pneumococcal conjugate vaccine), Merck/MSD Argentina (HPV vaccine), as well as collaborations with Elea Laboratories and Insud Pharma/mAbxience to produce monoclonal antibodies. Its products are distributed across Latin America. The company’s clinical results include large-scale commercial supply of influenza (~13 million doses/year), pneumococcal conjugate vaccines, HPV vaccines—and fill-finish operations for several monoclonal antibody biosimilars through its partners.